LIXTW (Lixte Biotechnology Holdings) OCF Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LIXTW Lixte Biotechnology Holdings Inc LIXTW
34 GF Score
Price $0.02
! 1 Warning Sign
View Full Analysis

What is Lixte Biotechnology Holdings OCF Margin %?

Lixte Biotechnology Holdings LIXTW +4.74% 34 OCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates LIXTW with a GF Score™ of 34/100. The stock has 1 warning sign investors should review. Among 3,049 Industrial Products companies, Lixte Biotechnology Holdings ranks worse than 32797.61% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Lixte Biotechnology Holdings's Cash Flow from Operations for the three months ended in Jun. 2026 was $-1.61 Mil. Lixte Biotechnology Holdings's Revenue for the three months ended in Jun. 2026 was $0.00 Mil. Therefore, Lixte Biotechnology Holdings's OCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.

As of today, Lixte Biotechnology Holdings's current OCF Yield % is -7.79%.

The historical rank and industry rank for Lixte Biotechnology Holdings's OCF Margin % or its related term are showing as below:


LIXTW's OCF Margin % is not ranked *
in the Industrial Products industry.
Industry Median: 6.62
* Ranked among companies with meaningful OCF Margin % only.

Lixte Biotechnology Holdings OCF Margin % Related Terms

Lixte Biotechnology Holdings OCF Margin % Historical Data

* Premium members only.

The historical data trend for Lixte Biotechnology Holdings's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lixte Biotechnology Holdings OCF Margin % Chart

Lixte Biotechnology Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lixte Biotechnology Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LIXTW
34GF Score
Lixte Biotechnology Holdings Inc LIXTW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lixte Biotechnology Holdings OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Lixte Biotechnology Holdings's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.071/0
= %

Lixte Biotechnology Holdings's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-1.612/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Lixte Biotechnology Holdings (LIXTW) has a OCF Margin % of 0.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Lixte Biotechnology Holdings and its competitors. According to the industry distribution chart, Lixte Biotechnology Holdings ranks #999999 out of 3049 companies in the Industrial Products industry.
Is Lixte Biotechnology Holdings' OCF Margin % too high?
Lixte Biotechnology Holdings' current OCF Margin % is 0.00%. Based on the distribution chart, Lixte Biotechnology Holdings ranks #999999 out of 3049 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Lixte Biotechnology Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Lixte Biotechnology Holdings' OCF Margin % compare to CBAT and TGEN?
According to the Industrial Products industry distribution chart, Lixte Biotechnology Holdings ranks #999999 out of 3049 companies for OCF Margin %. This places Lixte Biotechnology Holdings in the lower half of its industry. The industry median OCF Margin % is 6.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for an Industrial Products company?
The median OCF Margin % among Industrial Products companies is 6.62, based on 3,049 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Lixte Biotechnology Holdings and its competitors. For the Industrial Products industry, the median OCF Margin % is 6.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lixte Biotechnology Holdings's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lixte Biotechnology Holdings stock overvalued right now?
Lixte Biotechnology Holdings (LIXTW) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Lixte Biotechnology Holdings' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Lixte Biotechnology Holdings (LIXTW), the current OCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lixte Biotechnology Holdings Business Description

Other Exchanges LIXT:USA
Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.
34GF Score

Get the complete analysis for LIXTW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price